TYK MEDICINES-B (Stock Code: 02410) disclosed that as of 28 February 2026, the company had approximately 375.46 million H shares. On 4 March 2026, 4.61 million unlisted shares were converted into H shares, representing about 1.23% of the existing H shares before the conversion. Following this change, the total issued H shares reached approximately 380.07 million, and the unlisted shares balance was reduced to zero.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.